Literature DB >> 7865639

Review article: gastroduodenal bicarbonate secretion.

D L Hogan1, M A Ainsworth, J I Isenberg.   

Abstract

The gastroduodenal epithelium is covered by an adherent mucus layer into which bicarbonate is secreted by surface epithelial cells. This mucus-bicarbonate barrier is an important first line of defence against damage by gastric acid and pepsin, and has been demonstrated in all species including human. Similar to gastric acid secretion, regulation of gastric and duodenal bicarbonate secretion can be divided into three phases: cephalic, gastric and duodenal. In humans, sham-feeding increases bicarbonate secretion in both the stomach and duodenum which is mediated by cholinergic vagal fibres in the stomach, but seems to be noncholinergic in the duodenum. Gastric distention and luminal acidification increases gastric bicarbonate production. Whereas there are no data relating to the gastric phase of human duodenal bicarbonate secretion, in animals, food and acid in the stomach independently stimulate duodenal bicarbonate output. To date, the duodenal phase of human gastric bicarbonate secretion has not been studied, but data from animals reveal that duodenal acidification augments bicarbonate secretion in the stomach. In all species tested, direct acidification of the duodenum is a potent stimulant of local bicarbonate production. In humans, the pH threshold for bicarbonate secretion is pH 3.0. Mediation of gastroduodenal bicarbonate secretion is provided by a variety of agonists and antagonists, tested mainly in animals, but some have been evaluated in humans. Prostaglandins of the E class and VIP are major factors that control bicarbonate secretion. Bicarbonate secretion, and the mucus-bicarbonate layer in general, is adversely effected by ulcerogenic factors such as aspirin, NSAIDs, bile salts, and cigarette smoking. Furthermore, duodenal ulcer patients have an impairment in bicarbonate production within the duodenal bulb, at rest and in response to stimulation. These findings indicate that the mucus-bicarbonate barrier is an important first line of defence in the pathogenesis of peptic ulcer disease.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7865639     DOI: 10.1111/j.1365-2036.1994.tb00319.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  21 in total

Review 1.  Overview: Helicobacter pylori and extragastric disease.

Authors:  Hidekazu Suzuki; Barry James Marshall; Toshifumi Hibi
Journal:  Int J Hematol       Date:  2006-11       Impact factor: 2.490

2.  Duodenal acid clearance in humans: observations made with intraluminal impedance recording.

Authors:  Guillaume Savoye; Jac Oors; André Smout
Journal:  Dig Dis Sci       Date:  2005-08       Impact factor: 3.199

3.  Measuring pH and Buffer Capacity in Fluids Aspirated from the Fasted Upper Gastrointestinal Tract of Healthy Adults.

Authors:  Chara Litou; Dimitrios Psachoulias; Maria Vertzoni; Jennifer Dressman; Christos Reppas
Journal:  Pharm Res       Date:  2020-01-27       Impact factor: 4.200

4.  Bicarbonate Induces Vibrio cholerae virulence gene expression by enhancing ToxT activity.

Authors:  Basel H Abuaita; Jeffrey H Withey
Journal:  Infect Immun       Date:  2009-06-29       Impact factor: 3.441

5.  Mechanisms of action of leptin in preventing gastric ulcer.

Authors:  Edward O Adeyemi; Salim A Bastaki; Irwin S Chandranath; Mohammed Y Hasan; Mohammed Fahim; Abdu Adem
Journal:  World J Gastroenterol       Date:  2005-07-21       Impact factor: 5.742

Review 6.  Gastrointestinal effects of aspirin.

Authors:  Carlos Sostres; Angel Lanas
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-06-07       Impact factor: 46.802

7.  Bicarbonate increases binding affinity of Vibrio cholerae ToxT to virulence gene promoters.

Authors:  Joshua J Thomson; Jeffrey H Withey
Journal:  J Bacteriol       Date:  2014-09-02       Impact factor: 3.490

8.  Bile acids and bicarbonate inversely regulate intracellular cyclic di-GMP in Vibrio cholerae.

Authors:  Benjamin J Koestler; Christopher M Waters
Journal:  Infect Immun       Date:  2014-05-05       Impact factor: 3.441

Review 9.  Purinergic regulation of duodenal surface pH and ATP concentration: implications for mucosal defence, lipid uptake and cystic fibrosis.

Authors:  J D Kaunitz; Y Akiba
Journal:  Acta Physiol (Oxf)       Date:  2011-01       Impact factor: 6.311

10.  Do elevated plasma vasoactive intestinal polypeptide (VIP) levels cause small intestinal motor disturbances in humans?

Authors:  Jutta Keller; Jan C Mueller-Wolf; Keihan Ahmadi-Simab; Christiane Fibbe; Ulrich Rosien; Peter Layer
Journal:  Dig Dis Sci       Date:  2005-02       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.